返回
Scinai Immunotherapeutics Ltd（SCNI）價格
SCNI 股價走勢圖
SCNI 收益
Scinai Immunotherapeutics Ltd
$0.86
-4.86%
$-0.04
收盤價：Jan 16, 16:00:00 GMT-5
$0.87
0.57%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$0.9092
開盤價
$0.954
當日範圍
$0.865 - $0.963
52週區間
$0.613 - $6.18
交易量
11.3K
平均成交量
52.4K
每股盈餘 (TTM)
0.00
股息收益率
--
市值
$2.7M
什麼是 SCNI？
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.